1. Home
  2. AVTE vs KLXE Comparison

AVTE vs KLXE Comparison

Compare AVTE & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTE
    SELLHOLDBUYas of a day ago
  • KLXE
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • AVTE 2018
  • KLXE 2018
  • Country
  • AVTE United States
  • KLXE United States
  • Employees
  • AVTE N/A
  • KLXE N/A
  • Industry
  • AVTE Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • AVTE Health Care
  • KLXE Energy
  • Exchange
  • AVTE Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • AVTE 72.5M
  • KLXE 83.1M
  • IPO Year
  • AVTE 2021
  • KLXE N/A
  • Fundamental
  • Price
  • AVTE $2.51
  • KLXE $3.50
  • Analyst Decision
  • AVTE Hold
  • KLXE Hold
  • Analyst Count
  • AVTE 7
  • KLXE 1
  • Target Price
  • AVTE $11.75
  • KLXE $4.50
  • AVG Volume (30 Days)
  • AVTE 62.3K
  • KLXE 206.4K
  • Earning Date
  • AVTE 03-27-2025
  • KLXE 03-12-2025
  • Dividend Yield
  • AVTE N/A
  • KLXE N/A
  • EPS Growth
  • AVTE N/A
  • KLXE N/A
  • EPS
  • AVTE N/A
  • KLXE N/A
  • Revenue
  • AVTE N/A
  • KLXE $709,300,000.00
  • Revenue This Year
  • AVTE N/A
  • KLXE $7.39
  • Revenue Next Year
  • AVTE N/A
  • KLXE $4.87
  • P/E Ratio
  • AVTE N/A
  • KLXE N/A
  • Revenue Growth
  • AVTE N/A
  • KLXE N/A
  • 52 Week Low
  • AVTE $1.25
  • KLXE $3.20
  • 52 Week High
  • AVTE $32.42
  • KLXE $8.13
  • Technical
  • Relative Strength Index (RSI)
  • AVTE 52.00
  • KLXE 39.69
  • Support Level
  • AVTE $2.44
  • KLXE $3.41
  • Resistance Level
  • AVTE $2.56
  • KLXE $3.65
  • Average True Range (ATR)
  • AVTE 0.09
  • KLXE 0.35
  • MACD
  • AVTE 0.00
  • KLXE -0.03
  • Stochastic Oscillator
  • AVTE 77.14
  • KLXE 18.29

Stock Price Comparison Chart: AVTE vs KLXE

AVTE
KLXE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202505101520253035AVTE VS KLXE

About AVTE Aerovate Therapeutics Inc.

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use